Andarine - Driada Medical

Andarine, commonly referred to as S4, was developed by GTx Inc. to address muscle wasting and benign prostatic hypertrophy. As a Selective Androgen Receptor Modulator (SARM), it selectively targets androgen receptors in muscle and bone while minimizing androgenic effects in other tissues. This selective binding makes it attractive for bodybuilders aiming to preserve lean mass and reduce fat without the severe side effects of anabolic steroids. Despite its initial promise, clinical development was discontinued, and it remains a gray-market compound for research purposes.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Andarine by Driada Medical, consult with your doctor or healthcare professional.